{"id":"NCT00210353","sponsor":"International Extranodal Lymphoma Study Group (IELSG)","briefTitle":"Randomized Trial of Chlorambucil Versus Chlorambucil Plus Rituximab Versus Rituximab in MALT Lymphoma","officialTitle":"Multicenter Randomized Trial of Chlorambucil Versus Chlorambucil Plus Rituximab Versus Rituximab in Extranodal Marginal Zone B-cell Lymphoma of Mucosa Associated Lymphoid Tissue (MALT Lymphoma)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2003-01","primaryCompletion":"2015-04","completion":"2016-02-17","firstPosted":"2005-09-21","resultsPosted":"2019-06-06","lastUpdate":"2019-06-06"},"enrollment":454,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Lymphoma, Mucosa-Associated Lymphoid Tissue"],"interventions":[{"type":"DRUG","name":"chlorambucil (drug)","otherNames":[]},{"type":"DRUG","name":"rituximab+chlorambucil","otherNames":[]},{"type":"DRUG","name":"rituximab","otherNames":[]}],"arms":[{"label":"ARM A","type":"ACTIVE_COMPARATOR"},{"label":"ARM B","type":"EXPERIMENTAL"},{"label":"ARM C (Since April 2006)","type":"EXPERIMENTAL"}],"summary":"Assess the therapeutic activity and safety of the combination of Chlorambucil and Rituximab in MALT lymphomas and determine whether the addition of Rituximab to Chlorambucil will improve the outcome of MALT lymphoma in comparison to treatment with Chlorambucil alone.\n\nIn April 2006, a third arm of treatment was added to compare the antitumor activity and safety of rituximab alone vs chlorambucil alone","primaryOutcome":{"measure":"Event-free-survival (EFS)","timeFrame":"5 years","effectByArm":[{"arm":"ARM A - Chlorambucil","deltaMin":51,"sd":null},{"arm":"ARM B - Rituximab + Chlorambucil","deltaMin":68,"sd":null},{"arm":"ARM C (Since April 2006) - Rituximab","deltaMin":51,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":75,"countries":["Belgium","France","Italy","Spain","Switzerland","United Kingdom"]},"refs":{"pmids":["37801707","23295789"],"seeAlso":["http://www.ielsg.org"]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":131},"commonTop":["Fatigue","Infection","Infusion related reactions","Nausea","Abdominal pain upper"]}}